IFNG and neoplasm: Only 4 out of 10 IFN-γ−/− chimeras were able to prevent SCC tumour growth, leading to reduced overall survival (Figure 8A; p = 0.006, Fisher’s exact test, and Figure 8B) despite having a similar bone marrow engraftment rate (Figure 8C).